Multi-resistent microbes are a growing danger. The often unnecessary and mass use of antibiotics causes the impassivity of pathogens against drugs. Infections that were easily curable up to now, may become life threatening. In just three hours, a new rapid test will give information on which available antibiotic is still effective in a concrete case.
The new technology could allow researchers to fit more biochemical probes onto a single biochip and reduce the cost of screening and analyzing changes associated with disease development, detecting bioterrorism agents, and other areas of research.
Every head movement changes the image of our environment that enters our eyes. We still perceive the world as stable, because our brain corrects for any changes in its visual information due to those head movements.
The first direct comparison of in vitro and in vivo screening techniques for identifying nanoparticles that may be used to transport therapeutic molecules into cells shows that testing in lab dishes isn't much help in predicting which nanoparticles will successfully enter the cells of living animals.
Microbial infections of the cornea can have serious consequences, including blindness in the worst case. The treatment of keratitis, a condition caused by certain pathogens, always presents major challenges to ophthalmologists. These corneal infections frequently cannot be successfully treated with the therapies currently available.
Every five minutes in Germany alone, a person dies of sudden cardiac arrest or fibrillation, the most common cause of death worldwide. This is partly due to the fact that doctors still do not fully understand exactly what goes on in the heart during the occurrence. Until now, it was impossible to visualize dynamic processes in the fibrillating heart muscle, or myocardium.
Peptides, short amino acid chains that control many functions in the human body, represent a billion-dollar market, also in the pharmaceutical industry. But, normally these medications must be injected. A research team led by the Technical University of Munich (TUM) has now determined how peptides can be designed so that they can be easily administered as a liquid or tablet.
Ginolis, a global supplier of production automation and dispensing solutions, today announced a distributor agreement with Darwin Microfluidics, an online supplier of microfluidic kits, products and...
Anetic Aid is a British company that has been designing, supplying and supporting equipment for a wide variety of clinical environments since 1977. Renowned for innovation and high quality, it listens...
Using the specialist expertise that has won them a worldwide reputation for rubber product design and engineering, UK-based Precision Dippings Manufacturing (PDM) has just supplied the watertight neck...
Image: Millirobot next to a cent piece; Copyright: MPI-IS
Robotics open up countless new possibilities for medical technology. Especially highly miniaturized robots could be increasingly used in minimally invasive surgery in the future. Researchers at the Max Planck Institute for Intelligent Systems have developed a mobile millirobot, which is able to move smoothly through rough terrain. They were mainly inspired by the world of insects.
The trend towards miniaturization is progressing in medical technology. This in turn also means that electronics must be adapted to size relations, for example of implants. Smaller structures and components are in demand as never before. Thus, the demands on the technology and production simultaneously grow.